回复：佩尔-乌诺·马尔姆斯特伦、理查德·J·西尔维斯特、大卫·E·克劳福德等人。一项针对比较膀胱内注射丝裂霉素C与卡介苗治疗非肌层浸润性膀胱癌的随机研究长期结果的个体患者数据荟萃分析。《欧洲泌尿外科杂志》2009年；56：247 - 56。 - Suppr | 超能文献

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.

作者信息

Aldemir Mustafa, Canda Abdullah Erdem, Balbay Mevlana Derya

出版信息

Eur Urol. 2010 Aug;58(2):e23; author reply e24-5. doi: 10.1016/j.eururo.2010.05.032. Epub 2010 Jun 2.

DOI:10.1016/j.eururo.2010.05.032

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.

Eur Urol. 2010 Aug;58(2):e23; author reply e24-5. doi: 10.1016/j.eururo.2010.05.032. Epub 2010 Jun 2.

2

Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.

Eur Urol. 2010 Feb;57(2):e7-9; author reply e10-1. doi: 10.1016/j.eururo.2009.10.033. Epub 2009 Nov 10.

3

An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer.

Eur Urol. 2009 Aug;56(2):247-56. doi: 10.1016/j.eururo.2009.04.038. Epub 2009 Apr 24.

4

Re: Willem Oosterlinck, Ziya Kirkali,Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guérin and with bacillus Calmette-Guérin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTCGenito-urinary Group Randomized Phase 2 Trial (30993). Eur Urol 2011;59:438-46.

Eur Urol. 2011 Jul;60(1):e1; author reply e2-3. doi: 10.1016/j.eururo.2011.03.050. Epub 2011 Apr 5.

5

Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up.

Eur Urol. 2009 Aug;56(2):260-5. doi: 10.1016/j.eururo.2009.04.009. Epub 2009 Apr 16.

6

Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?

Eur Urol. 2009 Aug;56(2):257-8; discussion 258-9. doi: 10.1016/j.eururo.2009.04.041. Epub 2009 May 3.

7

Re: Richard J. Sylvester, Maurizio A. Brausi, Wim J. Kirkels, et al. Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 2010;57:766-73.

Eur Urol. 2010 Jun;57(6):e57; author reply e58-9. doi: 10.1016/j.eururo.2010.02.037. Epub 2010 Mar 15.

8

Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression.

Urology. 2004 Apr;63(4):682-6; discussion 686-7. doi: 10.1016/j.urology.2003.11.049.

9

Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

Semin Urol Oncol. 1996 Feb;14(1 Suppl 1):10-6.

10

Re: Can early single dose instillation of epirubicin improve bacillus calmette-guerin efficacy in patients with nonmuscle invasive high risk bladder cancer? Results from a prospective, randomized, double-blind controlled study: T. Cai, G. Nesi, G. Tinacci, E. Zini, N. Mondaini, v. Boddi, s. Mazzoli and R. Bartoletti J Urol 2008; 180: 110-115.

J Urol. 2009 Jan;181(1):410. doi: 10.1016/j.juro.2008.09.053. Epub 2008 Nov 17.